Compile Data Set for Download or QSAR
Report error Found 49 Enz. Inhib. hit(s) with Target = 'Apolipoprotein B-100'
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107813({5-[(6-Methyl-4'-trifluoromethyl-biphenyl-2-carbon...)
Affinity DataIC50: 0.700nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107808(6-Methyl-4'-trifluoromethyl-biphenyl-2-carboxylic ...)
Affinity DataIC50: 0.900nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107774(4,6-Dimethyl-4'-trifluoromethyl-biphenyl-2-carboxy...)
Affinity DataIC50: 1nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107809({5-[(4,6-Dimethyl-4'-trifluoromethyl-biphenyl-2-ca...)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107797(4'-Fluoro-6-methyl-biphenyl-2-carboxylic acid (2-b...)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107790(4'-Trifluoromethyl-biphenyl-2-carboxylic acid (2-b...)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107772(4'-Fluoro-6-methyl-biphenyl-2-carboxylic acid [2-(...)
Affinity DataIC50: 1.40nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107804({2-[(6-Methyl-4'-trifluoromethyl-biphenyl-2-carbon...)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107803(6-Methyl-4'-trifluoromethyl-biphenyl-2-carboxylic ...)
Affinity DataIC50: 1.60nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107787((S)-6-methyl-N-(2-(pyridin-2-ylmethylamino)-2,3-di...)
Affinity DataIC50: 1.70nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107810(6-Methyl-4'-trifluoromethyl-biphenyl-2-carboxylic ...)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107812({5-[(6,4'-Bis-trifluoromethyl-biphenyl-2-carbonyl)...)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107775(4-{5-[(6-Methyl-4'-trifluoromethyl-biphenyl-2-carb...)
Affinity DataIC50: 1.80nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107815(6-Methyl-4'-trifluoromethyl-biphenyl-2-carboxylic ...)
Affinity DataIC50: 1.90nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107798({5-[(4'-Trifluoromethyl-biphenyl-2-carbonyl)-amino...)
Affinity DataIC50: 1.90nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107802(4'-Chloro-6-methoxy-biphenyl-2-carboxylic acid (2-...)
Affinity DataIC50: 2nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107800({2-[(4'-Chloro-6-methyl-biphenyl-2-carbonyl)-amino...)
Affinity DataIC50: 2nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107788({5-[(4-Methyl-4'-trifluoromethyl-biphenyl-2-carbon...)
Affinity DataIC50: 2.20nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107811({5-[(4,6-Dimethyl-4'-trifluoromethyl-biphenyl-2-ca...)
Affinity DataIC50: 2.20nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107805(6-Methyl-4'-trifluoromethyl-biphenyl-2-carboxylic ...)
Affinity DataIC50: 2.30nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107785({2-[(4,6-Dimethyl-4'-trifluoromethyl-biphenyl-2-ca...)
Affinity DataIC50: 2.40nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107792(4'-Chloro-6-methyl-biphenyl-2-carboxylic acid (2-b...)
Affinity DataIC50: 2.40nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107793({5-[(4,6-Dimethyl-4'-trifluoromethyl-biphenyl-2-ca...)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107781(6,4'-Dimethyl-biphenyl-2-carboxylic acid (2-benzen...)
Affinity DataIC50: 2.5nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107777(4,6-Dimethyl-4'-trifluoromethyl-biphenyl-2-carboxy...)
Affinity DataIC50: 2.60nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107770(4'-Chloro-6-methyl-biphenyl-2-carboxylic acid [2-(...)
Affinity DataIC50: 3nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107783({5-[(4'-Chloro-4,6-dimethyl-biphenyl-2-carbonyl)-a...)
Affinity DataIC50: 3.40nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107799({5-[(6-Methyl-4'-trifluoromethyl-biphenyl-2-carbon...)
Affinity DataIC50: 4.10nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107773(4'-Chloro-6-methyl-biphenyl-2-carboxylic acid (7-m...)
Affinity DataIC50: 5nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107814({5-[(4'-Trifluoromethyl-biphenyl-2-carbonyl)-amino...)
Affinity DataIC50: 5.20nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107771(4'-Cyano-6-methyl-biphenyl-2-carboxylic acid (2-be...)
Affinity DataIC50: 5.5nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107789((R)-methyl 5-(6-methyl-4'-(trifluoromethyl)bipheny...)
Affinity DataIC50: 6.40nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107779(6-Methyl-4'-trifluoromethyl-biphenyl-2-carboxylic ...)
Affinity DataIC50: 6.5nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107782(4'-Chloro-6-methyl-biphenyl-2-carboxylic acid (2-m...)
Affinity DataIC50: 6.60nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107794({5-[(4,4'-Bis-trifluoromethyl-biphenyl-2-carbonyl)...)
Affinity DataIC50: 7.5nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107784(4'-Fluoro-6-methyl-biphenyl-2-carboxylic acid (2-m...)
Affinity DataIC50: 8.30nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107767({5-[(4'-Chloro-6-methyl-biphenyl-2-carbonyl)-amino...)
Affinity DataIC50: 8.70nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107780(6-Methyl-4'-trifluoromethyl-biphenyl-2-carboxylic ...)
Affinity DataIC50: 8.80nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107766((2-{5-[(6-Methyl-4'-trifluoromethyl-biphenyl-2-car...)
Affinity DataIC50: 10nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107778(Biphenyl-2-carboxylic acid (2-benzenesulfonylamino...)
Affinity DataIC50: 12nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107791(4'-Chloro-6-methoxy-biphenyl-2-carboxylic acid (2-...)
Affinity DataIC50: 15nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107768(4'-Chloro-6-methyl-biphenyl-2-carboxylic acid [2-(...)
Affinity DataIC50: 16nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107806(4'-Trifluoromethyl-biphenyl-2-carboxylic acid (2-b...)
Affinity DataIC50: 42nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107807(4-{5-[(6-Methyl-4'-trifluoromethyl-biphenyl-2-carb...)
Affinity DataIC50: 43nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107769(4'-Trifluoromethyl-biphenyl-2-carboxylic acid (2-m...)
Affinity DataIC50: 60nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107796(4'-Trifluoromethyl-biphenyl-2-carboxylic acid (2-a...)
Affinity DataIC50: 120nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107795(4'-Trifluoromethyl-biphenyl-2-carboxylic acid [2-(...)
Affinity DataIC50: 120nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107801(4'-Trifluoromethyl-biphenyl-2-carboxylic acid (2-b...)
Affinity DataIC50: 270nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetApolipoprotein B-100(Human)
Novartis Institute For Biomedical Reasearch

Curated by ChEMBL
LigandPNGBDBM50107776(4'-Trifluoromethyl-biphenyl-2-carboxylic acid (2-b...)
Affinity DataIC50: 340nMAssay Description:Inhibition of apolipoprotein B (apoB) secreted by human hepatoma cells (Hep G2) at 100 nMMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed